Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Muscarinic acetylcholine receptor M1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | serotonin receptor | Muscarinic acetylcholine receptor M1 | 460 aa | 432 aa | 26.6 % |
Schistosoma mansoni | amine GPCR | Muscarinic acetylcholine receptor M1 | 460 aa | 463 aa | 27.0 % |
Echinococcus granulosus | biogenic amine 5HT receptor | Muscarinic acetylcholine receptor M1 | 460 aa | 432 aa | 26.6 % |
Schistosoma japonicum | ko:K04136 adrenergic receptor, alpha 1b, putative | Muscarinic acetylcholine receptor M1 | 460 aa | 462 aa | 23.4 % |
Loa Loa (eye worm) | hypothetical protein | Muscarinic acetylcholine receptor M1 | 460 aa | 425 aa | 22.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | acyl-CoA:cholesterol acyltransferase alpha ACAT1-alpha | 0.1057 | 0.1139 | 0.444 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0463 | 0.0265 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0463 | 0.0265 | 1 |
Onchocerca volvulus | 0.1864 | 0.2324 | 0.5 | |
Plasmodium falciparum | diacylglycerol O-acyltransferase | 0.1057 | 0.1139 | 0.5 |
Trypanosoma cruzi | diacylglycerol acyltransferase, putative | 0.1864 | 0.2324 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0463 | 0.0265 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0463 | 0.0265 | 1 |
Echinococcus granulosus | diacylglycerol O acyltransferase 1 | 0.1057 | 0.1139 | 0.0778 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0463 | 0.0265 | 1 |
Brugia malayi | diacylglycerol acyltransferase | 0.1057 | 0.1139 | 0.0778 |
Brugia malayi | diacylglycerol acyltransferase family protein | 0.1864 | 0.2324 | 0.2011 |
Schistosoma mansoni | diacylglycerol O-acyltransferase 1 | 0.1057 | 0.1139 | 0.0965 |
Toxoplasma gondii | acyl-CoA:diacylglycerol acyltransferase 1-related enzyme | 0.1057 | 0.1139 | 0.444 |
Trypanosoma brucei | diacylglycerol acyltransferase, putative | 0.1864 | 0.2324 | 1 |
Echinococcus multilocularis | diacylglycerol O acyltransferase 1 | 0.1057 | 0.1139 | 0.0778 |
Loa Loa (eye worm) | hypothetical protein | 0.709 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0413 | 0.0192 | 0.5 |
Plasmodium vivax | diacylglycerol O-acyltransferase, putative | 0.1057 | 0.1139 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0463 | 0.0265 | 1 |
Schistosoma mansoni | alpha-13-mannosyl-glycoprotein beta-1 2-n-acetylglucosaminyltransferase | 0.0548 | 0.0391 | 0.0203 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0463 | 0.0265 | 1 |
Toxoplasma gondii | dgat2l1-prov protein | 0.1864 | 0.2324 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.088 | 0.0878 | 0.0506 |
Loa Loa (eye worm) | diacylglycerol acyltransferase | 0.1864 | 0.2324 | 0.2011 |
Schistosoma mansoni | beta-12-n-acetylglucosaminyltransferase II | 0.709 | 1 | 1 |
Schistosoma mansoni | diacylglycerol O-acyltransferase 1 | 0.1864 | 0.2324 | 0.2173 |
Loa Loa (eye worm) | diacylglycerol acyltransferase | 0.1057 | 0.1139 | 0.0778 |
Echinococcus multilocularis | alpha 1,6 mannosyl glycoprotein | 0.709 | 1 | 1 |
Echinococcus granulosus | alpha 16 mannosyl glycoprotein | 0.709 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0463 | 0.0265 | 1 |
Leishmania major | diacylglycerol acyltransferase, putative | 0.1864 | 0.2324 | 1 |
Trypanosoma cruzi | diacylglycerol acyltransferase, putative | 0.1864 | 0.2324 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 56 % | Allosteric modulation at rat M1 receptor expressed in CHO cells by calcium mobilization assay relative to acetylcholine | ChEMBL. | 21194936 |
EC50 (functional) | = 5.1 uM | Allosteric modulation at rat M1 receptor expressed in CHO cells by calcium mobilization assay | ChEMBL. | 21194936 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.